Metastatic NSCLC (mNSCLC) Biomarkers and Prognostic Factors

Specialists review specific prognostic factors and biomarkers that help guide treatment selection for patients with metastatic NSCLC (mNSCLC) and discuss if these biomarkers differ from those observed in early-stage NSCLC.

Related Keywords

David Carbone , Martin Dietrich , , Nsclc , Non Small Cell Lung Cancer , Biomarkers , Prognostic Factors , Treatment Selection , Mnsclc , Early Stage Nsclc , Neoadjuvant , Pd L1 Gt 50 , Pd L1 Lt 49 , Pl L1 Lt 1 ,